UPL-20743-64343
3 vaccinations
1 coded response
34 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 773 / TX
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Moderna
-
2021-01-12
Registered in v-safe
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-17
- 2021-01-18
- 2021-01-27
- 2021-02-03
-
2021-02-08
Dose 2 — Moderna
- 2021-02-08
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-02-14
- 2021-03-03
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-05-12
- 2021-08-09
-
2021-10-23
Dose 3 — Moderna
- 2021-10-23
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-29
- 2021-10-30
- 2021-11-08
- 2021-11-15
- 2021-11-27
- 2021-12-06
- 2022-01-22
- 2022-04-25
-
2022-10-23
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Another round of covidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-26
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Moderna | |
| 2 | 2021-02-08 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 12 months, dose 3
Symptoms: Another round of covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release